Author

T. L. Meister

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 6 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 8 Research Focus:host-pathogen & immune response· 6 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Organism:virus· 1

Frequent Co-Authors

E. Steinmann· 7 shared S. Pfaender· 7 shared A. Krawczyk· 6 shared D. Todt· 6 shared U. Dittmer· 4 shared B. Becker· 3 shared D. Paulmann· 3 shared B. Bischoff· 2 shared

Activity by Year

2020-2022 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

7 shared papersMicrobiology

E. Steinmann

Mutual co-authors in cluster

Author profile →

8 papers

Recent·Most cited

SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications

A. Schloer, S. Hirschberg, G. Ben Amor, T. L. Meister, P. Arora, S. Pöhlmann, M. Hoffmann, S. Pfaender, O. Kamal Eddin, J. Kamhieh-Milz, K. Hanack

This study identifies camelid heavy-chain-only antibodies that effectively neutralize SARS-CoV-2 and its variants, showing potential for diagnostic and therapeutic applications.

bioRxiv · Mar 24, 2022Immunology

Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infection

J. Schuhenn, T. L. Meister, D. Todt, T. Bracht, K. Schork, J.-N. Billaud, C. Elsner, N. Heinen, Z. Karakoese, S. Haid, S. Kumar, L. Brunotte, M. Eisenacher, J. Chen, Z. Yuan, , S. Pfaender

The paper identifies differential antiviral effects of IFN-alpha subtypes against SARS-CoV-2 and highlights IFN5's superior activity, suggesting therapeutic potential.

bioRxiv · May 20, 2021 · PreprintCell Biology

Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1.351

T. L. Meister, J. Fortmann, D. Todt, N. Heinen, A. Ludwig, Y. Brueggemann, C. Elsner, U. Dittmer, S. Pfaender, E. Steinmann

This study compares the environmental stability and disinfection profiles of SARS-CoV-2 variants B.1.1.7 and B.1.351 to the wildtype, finding comparable susceptibility to disinfection and surface stability.

bioRxiv · Apr 7, 2021Microbiology

A realistic touch-transfer method reveals low risk of transmission for SARS-CoV-2 by contaminated coins and bank notes

D. Todt, T. L. Meister, B. Tamele, J. Howes, D. Paulmann, B. Becker, F. H. Brill, M. Wind, J. Schijven, B. Mhlekude, C. Goffinet, A. Krawczyk, J. Steinmann, S. Pfaender, Y. Brueggemann, E. Steinmann

This study assesses the risk of SARS-CoV-2 transmission via contaminated coins and banknotes using a novel touch transfer method and shows it is unlikely under typical conditions.

bioRxiv · Apr 2, 2021Microbiology

Disinfection of SARS-CoV-2 contaminated surfaces of personal items with UVC-LED disinfection boxes

M. Bormann, M. Alt, L. Schipper, L. van de Sand, M. Otte, T. L. Meister, U. Dittmer, O. Witzke, E. Steinmann, A. Krawczyk

This study evaluates the effectiveness of UVC-LED disinfection boxes in inactivating SARS-CoV-2 on personal item surfaces, showing significant viral load reduction after 3 minutes of exposure.

bioRxiv · Mar 3, 2021Microbiology

Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2

K. Steinhauer, T. L. Meister, D. Todt, A. Krawczyk, L. Passvogel, B. Becker, D. Paulmann, B. Bischoff, M. Eggers, S. Pfaender, F. Brill, E. Steinmann

This study shows that three disinfectant formulations effectively inactivate SARS-CoV-2, supporting their use as preventive measures against enveloped viruses.

bioRxiv · Nov 8, 2020Microbiology

Comparison of the in vitro-efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476

K. Steinhauer, T. L. Meister, D. Todt, A. Krawczyk, L. Passvogel, B. Becker, D. Paulmann, B. Bischoff, S. Pfaender, F. Brill, E. Steinmann

This study evaluates the in vitro efficacy of chlorhexidine and octenidine mouthwashes against SARS-CoV-2 using EN 14476 standards, finding octenidine effective within 15 seconds.

bioRxiv · Oct 25, 2020Microbiology

Holder Pasteurization Inactivates SARS-CoV-2 in Human Breast Milk

C. Conzelmann, R. Gross, T. L. Meister, D. Todt, A. Krawczyk, U. Dittmer, S. Stenger, J. Muench, E. Steinmann, J. A. Mueller, S. Pfaender

This study shows that Holder pasteurization inactivates SARS-CoV-2 in human breast milk, offering a safe method for infected mothers to breastfeed.

bioRxiv · Jun 17, 2020 · PreprintMicrobiology